Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility

Irene Catucci, Paolo Peterlongo, Therese Törngren et al.|Genetics in Medicine|2017

Cited by 93